Quoting my own post again as it is so important. Don’t show more bias and stigma employers by making people jump through hoops to get treatment. Just provide good comprehensive care!

Go Dr Emeline Aviki, MD, MBA!! nyulangone.org/news/perlmutte…

I’m really excited to be able to share more about what I’ve been working on for the last couple of years! Couldn’t be more thrilled to be working with Josh Haimson and the rest of this super talented team on the important problem of getting better drugs to the clinic, faster.

I’m excited to start sharing more publicly what I’ve been working on for the last couple of years! At Inductive, we're focused on delivering better therapies to patients, faster, by accelerating compound optimization with fit-for-purpose datasets and ML

#ML #AI #DrugDiscovery

World, meet Inductive Bio!

An ML-powered platform to learn from large datasets + accelerate small molecule optimization. Co-founded by Josh Haimson + Ben Birnbaum, who previously started and ran the ML team Flatiron Health (where we met). Excited to be working together again!

Super thrilled to see Tome Biosciences come out of stealth to translate the vision of programmable gene replacement as a new editing modality for genomic medicines and cell therapy. Started this company with Jonathan Gootenberg to solve challenges in the gene therapy and gene editing fields. 🧵👇

.🧬🚀 Vineeta Agarwala and I couldn't be more excited to have the opportunity to support Mana Bio as they pioneer the field of AI designed LNPs for next generation delivery of genetic medicines. Huge congrats to Mana co-founders Yogev Debbi, Avi Schroeder, Kira Radinsky and Roy Nevo !!

So happy to be joining as an advisory partner at a16z a16zBioHealth to help usher in the next-generation of biotechs, therapies, and therapeutic modalities with Jorge Conde Becky Pferdehirt Vineeta Agarwala Vijay Pande Ben Portney Zak Doric, PhD and team!! bio-eats-world.simplecast.com/episodes/partn…

Exciting milestone for Thyme Care: Series B to support many more cancer patients in their care journeys.

Welcome to new partners Town Hall Ventures and Foresite Capital and congrats to the Thyme Care team!

Hot on the heels of their Seed announcement, Amber Bio is unveiling Splice Editing – a novel gene editing method leveraging endogenous splicing machinery and newly discovered CRISPR-Cas systems to achieve large edits. Preprint by Jacob Borrajo Basem Al-Shayeb, Ph.D. 🧬 & team👇cc Vineeta Agarwala

Congrats Jacob Borrajo Basem Al-Shayeb, Ph.D. 🧬 and the team at Amber Bio!

Timmerman Traverse for Life Science Cares 2023. The team raised $1.23 million to fight poverty. Ready to go hike the Presidential Traverse! Thanks to all the hikers and donors.

We are hiring a lab manager/tech for the new lab at DFCI! Please apply or get in touch if interested! The job will be part management and part science - very flexible - careers.dana-farber.org/job/senior-res…

Excited to read!

Patients, their families, and their oncologists battling kidney cancer have a new potential clinical option with HPK1 inhibition, an oral small molecule, non-checkpoint approach to fighting their cancer with their own immune system. More below and at NimbusTx.com

We are thrilled to welcome Greg Verdine to the a16z Bio + Health team as a Venture Partner!

Greg is a unique leader in both the academic + biotech worlds, a new drug modality pioneer, and a serial founder.

🎧 More below, and Greg's story in his own voice! a16z.com/2023/07/20/gre…